Assessing AtaiBeckley (ATAI) Valuation After Strong Returns And Elevated Price To Book Ratio

Why AtaiBeckley (ATAI) is on investors’ radar AtaiBeckley (ATAI) has been drawing attention after a strong past 3 months for ...

AtaiBeckley nears key clinical catalysts, Jefferies stays positive with repeat ‘Buy’ rating

AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) has kept Jefferies analysts bullish on the company following a fireside chat in New ...

AtaiBeckley Inc.

View AtaiBeckley Inc. ATAI stock quote prices, financial information, real-time forecasts, and company news from CNN.
Nasdaq

atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression

NEW YORK, and AMSTERDAM and OXFORD, United Kingdom, July 01, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company on a mission to develop ...
Seeking Alpha

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies

NEW YORK and BERLIN and OXFORD, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (ATAI) (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a ...
Seeking Alpha

atai Life Sciences Announces Positive Topline Results from Beckley Psytech’s BPL-003 (intranasal 5-MeO-DMT benzoate) Phase 2a Open-Label Study for Alcohol Use Disorder

NEW YORK and BERLIN, Jan. 28, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (ATAI) (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of ...
Benzinga.com

Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients

Atai Life Sciences (NASDAQ:ATAI) and Beckley Psytech Limited, a private clinical-stage biopharmaceutical company, released data from a proof-of-concept study investigating a two-dose induction regimen ...
Bloomberg L.P.

Atai Shares Rise on Beckley’s Psychedelic Drug Study Success

Atai Life Sciences NV shares climbed after a psychedelic nasal spray from Beckley Psytech Ltd, the company it plans to acquire, significantly eased depression symptoms in a mid-stage trial. The study ...
Insider Monkey

Atai Beckley N.V. (ATAI) is a Buy on Mental Therapeutics Opportunities

Atai Beckley N.V. (NASDAQ:ATAI) is one of the best penny stocks to buy in 2026. On December 23, Jones Trading initiated coverage of Atai Beckley N.V. (NASDAQ:ATAI) with a Buy rating and a $16 price ...
Insider Monkey

JonesTrading Highlights Differentiated Pipeline at Atai Beckley N.V. (ATAI)

Atai Beckley N.V. (NASDAQ:ATAI) is among the Best Get Rich Fast Stocks to Buy Right Now. On December 23, Justin Walsh from JonesTrading initiated coverage on Atai Beckley N.V. (NASDAQ:ATAI) with a ...
Yahoo Finance

Atai Beckley N.V. (ATAI) Receives Buy Rating on BPL-003 Edge against Spravato

Atai Beckley NV (NASDAQ:ATAI) is a must-buy penny stock to buy now. On November 12, TD Cowen’s Ritu Baral reaffirmed a Buy rating on Atai Beckley NV (NASDAQ:ATAI), pointing to encouraging clinical ...
Nasdaq

atai Life Sciences and Beckley Psytech Announce Positive Phase 2b Results for BPL-003 in Treatment-Resistant Depression

Atai Life Sciences and Beckley Psytech announced positive results from a Phase 2b clinical trial evaluating BPL-003, a treatment for treatment-resistant depression (TRD). The study achieved its ...